Scientists have identified an enzyme that may act as a natural defense against the worsening of fatty liver disease, which ...
For millions of people living with metabolic dysfunction-associated steatohepatitis (MASH), treatment options remain limited.
Novo reports analysis from STEP UP trial sub-population in which most participants with elevated liver fat achieved improved liver health after 72 weeks of Wegovy® (injectable semaglutide 7.2 and 2.4 ...
A systematic review suggests transient elastography and biomarker combinations may aid liver fibrosis assessment in ...
When a patient arrives at the hospital with an acetaminophen overdose, it's often a race against the clock. The only FDA-approved antidote for overdose-related liver injury, N‑acetylcysteine, must be ...
Experimental compound targets key disease pathways in MASH, reducing fat, inflammation and scarring in preclinical models — with hopes for future patient trials.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results